This report describes the Global Market Size of Intracranial Stenosis Stents Market Size, Share & Trends Report Market from 2018 to 2021 and its CAGR from 2018 to 2021, and also forecasts its market size to the end of 2030 and its expected to grow with a CAGR of 4.8% from 2023 to 2030.
Intracranial stenosis refers to the narrowing of blood vessels within the brain. When blood flow is restricted by stenosis, the brain tissue receives less oxygen and nutrients, which can cause a variety of neurological symptoms or even strokes.The desire for minimally invasive intracranial procedures, the rising incidence of stroke, and the steadily expanding elderly population are all contributing to the market's expansion.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Intracranial Stenosis Stents Market Size, Share & Trends Report Market estimated at US $ million in the year 2022, is projected to reach a revised size of US$ million by 2030, growing at a CAGR of 4.8% during the forecast period 2023-2030. North American market for Intracranial Stenosis Stents Market Size, Share & Trends Report Market is estimated to increase from $million in 2022 to reach $ million by 2030, at a CAGR of XX% during the forecast period of 2023 through 2030
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2030. This report cover following regions:
Middle East and Africa
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Intracranial Stenosis Stents Market Size, Share & Trends Report Market as well as some small players. The information for each competitor include:
Main Business Information
Sales Volume, Revenue, Price and Gross Margin
By Product Type
Embolization Coil Support Intracranial Stents
Venous Sinus Stents
Balloon-expanding & Other stents
Self-expanding stents dominated the market by product in 2022, accounting for 34.86% of global revenue. Since intracranial stenosis is associated with a higher risk of ischemic stroke, self-expandable stents (SES) are anticipated to be safe for flow restoration in circumstances of acute ischemic strokes.
By End Use
Ambulatory Surgical Centers
With 81.00% of the market, the hospital end-use segment led, which may be attributable to the increased incidence of stenosis, aneurysms, brain strokes, and neurovascular illnesses. Sales of goods have grown as a result of the rising demand for products like self-expanding stents, venous sinus stents, balloon-expanding stents, and other stents in neurosurgery. In addition, a major driver of market expansion is the use of innovative technology-based medical equipment in hospitals. On the other hand, the market has grown as a result of the increase in neurosurgeries carried out in hospitals.
Middle East & Africa
In 2022, North America held the highest share with 36.3%. High rates of hypertension and stroke as well as the existence of well-established medical facilities are what are fueling the region's expansion. Over the course of the forecast period, the intracranial stenosis stent market in Asia Pacific is anticipated to expand at the quickest pace, 5.7%. This can be ascribed to elements including the region's expanding older population, unhealthful lifestyle choices and stress, rising ischemic stroke incidence, huge population, and rising patient affordability. Furthermore, the expansion of the regional industry is probably aided by the lucrative development prospects in emerging markets like China and India.
MicroPort Scientific Corporation
CERENOVUS (Johnson & Johnson)
Sino Medical Sciences Technology, Inc.
Please ask for sample pages for full companies list
Base Year: 2022
Historical Data: from 2018 to 2021
Forecast Data: from 2023 to 2030
Any special requirements about this report, please let us know and we can provide custom report.